Association of circulating tumor DNA (ctDNA) detection in metastatic renal cell carcinoma (mRCC) with tumor burden

被引：2

作者：

Maia, Manuel Caitano

Bergerot, Paulo Gustavo

Dizman, Nazli

Hsu, Joann

Jones, Jeremy

Choueiri, Toni K.

Sonpavde, Guru

Lannnan, Richard B.

Banks, Kimberly

Pal, Sumanta K.

机构：

[1] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil

[2] Fed Univ Sao Paulo UNIFESP, Sao Paulo, Brazil

[3] Istanbul Medeniyet Univ Hosp, Istanbul, Turkey

[4] City Hope Natl Med Ctr, Duarte, CA USA

[5] Dana Farber Canc Inst, Boston, MA 02115 USA

[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[7] Univ Alabama Birmingham, Birmingham Comprehens Canc Ctr, Birmingham, AL USA

[8] Guardant Hlth Inc, Redwood City, CA USA

[9] City Hope Comprehens Canc Ctr, Duarte, CA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.4582

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4582

引用

页数：5

共 50 条

[1] Cell-free Circulating Tumor DNA (ctDNA) in Metastatic Renal Cell Carcinoma (mRCC): Current Knowledge and Potential Uses
Hahn, Andrew W.
Nussenzveig, Roberto H.
Maughan, Benjamin L.
Agarwal, Neeraj
[J]. KIDNEY CANCER, 2019, 3 (01) : 7 - 13
[2] Circulating tumor DNA sequencing analysis of patients with metastatic renal cell carcinoma (mRCC).
Zengin, Zeynep Busra
Dizman, Nazli
Salgia, Nicholas
Jones, Jeremy
Zhang, Jingbo
Liu, Yunchao
Xu, Bing
Li, Fuwei
Wang, Yan
Li, Mengjian
Du, Rong
Zhou, Ye
Hsu, Joann
Salgia, Meghan
Yang, Lixin
Pal, Sumanta K.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[3] Correlation between depression/anxiety and somatic circulating tumor DNA (ctDNA) alterations in patients with metastatic renal cell carcinoma (mRCC).
Bergerot, Cristiane Decat
Bergerot, Paulo Gustavo
Clark, Karen L.
Loscalzo, Matthew J.
Lanman, Richard B.
Banks, Kimberly
Pal, Sumanta K.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
[4] Tumor burden as an independent prognostic factor in metastatic renal cell carcinoma (mRCC).
Escudier, Bernard J.
Iacovelli, Roberto
Lanoy, Emilie
Albiges, Laurence
Fizazi, Karim
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
[5] Prognostic value of circulating tumor DNA fraction (TF) for patients with metastatic renal cell carcinoma (mRCC).
Zurita, Amado J.
Danziger, Natalie
Scott, Takara
Gjoerup, Ole
Zhong, Lei
Tukachinsky, Hanna
Ross, Jeffrey S.
Graf, Ryon
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 455 - 455
[6] Circulating tumor DNA analysis of metastatic renal cell carcinoma
Zhang, Jingbo
Liu, Yunchao
Xu, Bing
Li, Fuwei
Wang, Yan
Li, Mengjian
Du, Rong
Zhou, Ye
Salgia, Meghan
Yang, Lixin
Jones, Jeremy O.
[J]. MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (01) : 1 - 5
[7] Association of tumor burden characteristics with outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib
Golshayan, A. R.
Elson, P.
Wood, L. S.
Garcia, J. A.
Dreicer, R.
Rini, B. I.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[8] Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications
Hahn, Andrew W.
Gill, David M.
Maughan, Benjamin
Agarwal, Archana
Arjyal, Lubina
Gupta, Sumati
Streeter, Jessica
Bailey, Erin
Pal, Sumanta K.
Agarwal, Neeraj
[J]. ONCOTARGET, 2017, 8 (20) : 33614 - 33620
[9] Assessment of circulating cell-free tumor DNA (ctDNA) in 847 patients (pts) with metastatic renal cell carcinoma (mRCC) and concordance with tissue-based testing
Zengin, Z. B.
Weipert, C.
Hsu, J.
Salgia, N.
Saam, J.
Choueiri, T. K.
Agarwal, N.
Pal, S.
[J]. ANNALS OF ONCOLOGY, 2020, 31 : S553 - S554
[10] Detection of circulating tumor DNA in patients with metastatic clear cell renal cell carcinoma.
Nappi, Lucia
Bacon, Jack
Annala, Matti
Soleimani, Maryam
Lavoie, Jean-Michel
Chi, Kim N.
Wyatt, Alexander William
Kollmannsberger, Christian K.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)

← 1 2 3 4 5 →